Rice Hall James & Associates LLC lessened its holdings in Amdocs Limited (NASDAQ:DOX - Free Report) by 9.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 151,658 shares of the technology company's stock after selling 15,365 shares during the period. Rice Hall James & Associates LLC owned about 0.13% of Amdocs worth $12,912,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Janus Henderson Group PLC boosted its holdings in Amdocs by 1.7% in the 3rd quarter. Janus Henderson Group PLC now owns 6,625,875 shares of the technology company's stock worth $579,632,000 after buying an additional 111,357 shares during the last quarter. Pzena Investment Management LLC boosted its holdings in Amdocs by 12.3% in the 3rd quarter. Pzena Investment Management LLC now owns 6,363,739 shares of the technology company's stock worth $556,700,000 after buying an additional 696,136 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its holdings in Amdocs by 2.8% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 3,263,591 shares of the technology company's stock worth $274,681,000 after buying an additional 87,801 shares during the last quarter. Wellington Management Group LLP boosted its holdings in Amdocs by 0.8% in the 3rd quarter. Wellington Management Group LLP now owns 2,136,932 shares of the technology company's stock worth $186,939,000 after buying an additional 16,580 shares during the last quarter. Finally, Pacer Advisors Inc. boosted its holdings in Amdocs by 7.4% in the 4th quarter. Pacer Advisors Inc. now owns 1,815,675 shares of the technology company's stock worth $154,587,000 after buying an additional 125,654 shares during the last quarter. Hedge funds and other institutional investors own 92.02% of the company's stock.
Wall Street Analyst Weigh In
Several research firms recently issued reports on DOX. StockNews.com cut Amdocs from a "strong-buy" rating to a "buy" rating in a report on Wednesday. Oppenheimer boosted their target price on Amdocs from $98.00 to $105.00 and gave the stock an "outperform" rating in a report on Wednesday, November 13th. Finally, Barclays lowered their target price on Amdocs from $113.00 to $111.00 and set an "overweight" rating on the stock in a report on Thursday, November 14th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $101.20.
Get Our Latest Report on DOX
Amdocs Price Performance
Shares of Amdocs stock traded down $1.40 on Friday, hitting $87.91. 726,643 shares of the company were exchanged, compared to its average volume of 651,589. Amdocs Limited has a 1-year low of $74.41 and a 1-year high of $94.04. The stock has a market capitalization of $9.92 billion, a price-to-earnings ratio of 20.40, a price-to-earnings-growth ratio of 1.48 and a beta of 0.71. The company has a 50-day moving average price of $86.06 and a 200 day moving average price of $86.56. The company has a quick ratio of 1.20, a current ratio of 1.16 and a debt-to-equity ratio of 0.22.
Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The technology company reported $1.45 EPS for the quarter, missing analysts' consensus estimates of $1.64 by ($0.19). Amdocs had a net margin of 10.19% and a return on equity of 18.89%. As a group, sell-side analysts predict that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.
Amdocs Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Sunday, April 20th. Shareholders of record on Monday, March 31st will be given a $0.527 dividend. This is a positive change from Amdocs's previous quarterly dividend of $0.48. The ex-dividend date is Monday, March 31st. This represents a $2.11 dividend on an annualized basis and a yield of 2.40%. Amdocs's payout ratio is presently 44.55%.
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Stories
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
